Randomized Clinical Trials — Removing Unnecessary Obstacles
- 12 September 2013
- journal article
- editorial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 369 (11), 1061-1065
- https://doi.org/10.1056/nejmsb1300760
Abstract
The authors, who are experienced clinical trialists, propose a framework for expediting the conduct of clinical trials and reducing what they perceive as unnecessary bureaucracy in current trial regulations.Keywords
This publication has 18 references indexed in Scilit:
- Risk, Consent, and SUPPORTThe New England Journal of Medicine, 2013
- Informed Consent and SUPPORTThe New England Journal of Medicine, 2013
- How Variability in the Institutional Review Board Review Process Affects Minimal-Risk Multisite Health Services ResearchAnnals of Internal Medicine, 2012
- Clinical research: time for sensible global guidelinesThe Lancet, 2011
- The Unintended Consequences of Clinical Trials RegulationsPLoS Medicine, 2009
- Specific barriers to the conduct of randomized trialsClinical Trials, 2008
- Clinical trials bureaucracy: unintended consequences of well-intentioned policyClinical Trials, 2006
- Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trialThe Lancet, 2004
- Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trialsThe Lancet, 2001
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionThe New England Journal of Medicine, 1989